April 24th, 2014First Amendment of License Agreement • September 18th, 2017 • OptiNose, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 18th, 2017 Company IndustryThis letter confirms our understanding and agreement with respect to the assignment by OptiNose to Avanir of IND No. 110090. Unless otherwise defined in this letter, all initially capitalized terms used in this letter shall have the meanings given to such terms in the Agreement.